Sonoma Pharmaceuticals
SNOA
#10606
Rank
NZ$6.04 M
Marketcap
NZ$3.47
Share price
-8.89%
Change (1 day)
-11.33%
Change (1 year)

Earnings for Sonoma Pharmaceuticals (SNOA)

Earnings in 2025 (TTM): -NZ$5.37 Million

According to Sonoma Pharmaceuticals's latest financial reports the company's current earnings are NZ$16.93 Million. In 2024 the company made an earning of -NZ$7.56 Million a decrease over its 2023 earnings that were of -NZ$7.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Sonoma Pharmaceuticals from 2005 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$5.37 Million-29.02%
2024 -NZ$7.56 Million0.54%
2023 -NZ$7.52 Million-31.5%
2022 -NZ$10.98 Million16.86%
2021 -NZ$9.39 Million194.32%
2020 -NZ$3.19 Million-58.76%
2019 -NZ$7.74 Million-65.66%
2018 -NZ$22.53 Million4.84%
2017 -NZ$21.49 Million-2.17%
2016 -NZ$21.97 Million32.12%
2015 -NZ$16.63 Million-307.74%
2014 NZ$8 M-197.5%
2013 -NZ$8.21 Million
2010 -NZ$12.83 Million-14.02%
2009 -NZ$14.92 Million-57.28%
2008 -NZ$34.91 Million-8.03%
2007 -NZ$37.96 Million3.85%
2006 -NZ$36.55 Million39.31%
2005 -NZ$26.24 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-NZ$0.28 Billion 5,013.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-NZ$30.74 Million 482.11%๐Ÿ‡บ๐Ÿ‡ธ USA